Aurora Shares Q2 Fiscal 2018 Results

Aurora Cannabis (TSX:ACB; OTCQX:ACBFF) released its financial report for the second quarter of their fiscal 2018, resulting in $11.7 million in revenues.

As quoted in the press release:

Continued Strong Patient and Revenue Growth

  • As at the date of this release, the Company has over 23,000 active registered patients, up 5.9% from Q2 2018.
  • Recorded $11.7 million in revenues, up 201% from Q2 2017 and up 41.8% sequentially from Q1 2018. Revenues were generated as follows:

-Dried cannabis sold in Canada

$5.8 million, up 23.9% sequentially from Q1 2018;

-Dried cannabis sold in Germany

$2.5 million, up 101.1% sequentially;

-Service and other revenues

$2.0 million, up 109.7% sequentially, and

Management commentary

“Exceptional, high-paced execution has delivered another quarter with strong growth, as well as further expansion, vertical integration and diversification,” said Terry Booth, CEO. “With three production licenses, over 240,000 kg per annum in pro-forma funded capacity, multiple distribution channels, and the pending acquisition of CanniMed, we are well positioned to pursue accelerated growth in the domestic and international medical markets. Finally, our partnership with Liquor Stores N.A. shortens our time to market in creating a large bricks-and-mortar cannabis retail network in preparation for the adult consumer use market.”

Click here to read the full press release.

Source: www.newswire.ca

World High Life PLC Announces Total Voting Rights

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less

TransCanna Grants Stock Options

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it has granted an aggregate of 400,000 options at an exercise price of CDN$1.00, exercisable for a period of five years, to directors and officers of the Company. The stock options are being granted pursuant to the terms of the Company’s stock option plan, and are subject to regulatory approval.

About TransCanna Holdings Inc.

Keep reading... Show less

Trulieve Celebrates November Veterans Day with Donation to Veteran Programs

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

ACB Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aurora Cannabis, Inc. Shareholders With Losses Exceeding $110,000 of Class Action and Lead Plaintiff Deadline: December 1, 2020

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

ACB Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aurora Cannabis, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 1, 2020

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less